Active · per the CBE, 18 September 2026

XpressBioX

BE0770527814

Rechtspersoon Private limited company 1 establishment

XpressBioX is registered with the CBE as active in: Vervaardiging van farmaceutische grondstoffen. Private Limited, started on 30 June 2021, 1 establishment.

Avenue du Parc Industriel 89, 4041 Herstal

Active for

5 year, 2 months

Financials

Financial year 2025

XpressBioX from Herstal, company number BE0770527814, closed financial year 2025 with a result of € 74,621 after tax. For that financial year XpressBioX recorded revenue of € 198,000 and equity of € 8.9 million. Compared with financial year 2024, the result moved from € -50,833 to € 74,621. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 13, 2026.

What it is worth Growing

€ 8.9 million

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 74,621

▲ still € 50,833 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 0

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -304,198.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,023

▼ 35% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 147 days on average.

Taxes

€ 9,901

▲ 2% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Revenue € 466,644 € 198,000 € 198,000 € 198,000
Gross margin € -70,032 € 177,372 - -
Profit after taxes € -169,825 € -61,160 € -50,833 € 74,621 ▲ € 125,454
Equity € 8,940,974 € 8,879,814 € 8,828,981 € 8,903,602 ▲ 1%
Total debts € 10,581,718 € 11,856,535 € 85,002 € 14,924 ▼ 82%
Cash € 929,806 € 24,814 € 0 € 0
Retained profit € -266,826 € -327,986 € -378,819 € -304,198 ▲ € 74,621
Bank debt € 10,542,696 € 11,836,282 € 0 € 0
Balance sheet total € 19,522,692 € 20,736,349 € 8,913,983 € 8,918,526

Key figures of XpressBioX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to XpressBioX?

What happened at XpressBioX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Cédric VOLANTI stepped down as director. NBB
  • Franck BACKERS stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 74,621. Source: NBB ↗
  • Cédric VOLANTI became a director. NBB
  • Jonas Skjødt MOLLER stepped down as director. NBB
  • Jonas Skjødt MOLLER became a director. NBB
  • Franck BACKERS became a director. NBB
  • New establishment in Herstal. KBO

In short

From € 169,825 loss in 2022 to € 74,621 profit in 2025.

Best year ever: 2025, with € 74,621 profit.

Pays suppliers within 147 days on average.

Original PDFs at the National Bank ↗

A new publication or filing at XpressBioX? We notify you, reason included.

Follow XpressBioX

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

  1. Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
  2. We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
  3. In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Yes, I want that
See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies
  • De Lijn 8 June 2026 New annual account 2025

    filed on 8 June 2026

    What was left

    € 20 k ▼ 91%

    Money in the bank

    € 178 k ▼ 98%

    Open the dossier →

  • NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
  • bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Real filings at the National Bank

Management

Sartorius Polyplus SAS 100%
XpressBioX
Sartorius Xpress Biologics SA 100%

The shares are held by Sartorius Polyplus SAS (100%). It owns 100% of Sartorius Xpress Biologics SA itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Cédric VOLANTI

Director

Also active at: Sartorius Accessia Pharma, SARTORIUS STEDIM BELGIUM

since 2025 · until 2031

Jonas Skjødt MOLLER

Director

Also active at: Sartorius Xpress Biologics, ACCESSIA PHARMA

since 2024 · until 2025

Franck BACKERS

Managing director

Also active at: Sartorius Xpress Biologics, ACCESSIA PHARMA

since 2024 · until 2030

Shareholders

Sartorius Polyplus SAS

100%

Participations

Sartorius Xpress Biologics SA

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue du Parc Industriel 89

4041 Herstal

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Sartorius Xpress Biologics same network

€ 2.4 million revenue · 2025

Sartorius Accessia Pharma same network

€ 2.2 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0770.527.814
VAT number
BE 0770.527.814
Registered office
Avenue du Parc Industriel 89, 4041 Herstal
Names & denominations
XpressBioX
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
30 June 2021
Peppol
Active · Active since 25 Jun 2026
Activities · NACE

Vervaardiging van farmaceutische grondstoffen

Speur- en ontwikkelingswerk op biotechnologisch gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does XpressBioX do?
XpressBioX is registered with the CBE as active in: Vervaardiging van farmaceutische grondstoffen. Private Limited, started on 30 June 2021, 1 establishment.
What is the address of XpressBioX?
The registered office of XpressBioX is located at Avenue du Parc Industriel 89, 4041 Herstal.
Is XpressBioX still active?
Yes. According to the CBE (18 September 2026) XpressBioX is active, legal situation “Normale toestand”, started on 30 June 2021.
Is XpressBioX registered on Peppol?
Yes, XpressBioX is registered on the Peppol network with ID 0208:0770527814.
What is the enterprise number of XpressBioX?
The enterprise number of XpressBioX is BE0770527814.
When was XpressBioX founded?
XpressBioX was founded on 30 June 2021.